Litcius/Paper detail

U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines

Diane M. Gubernot, Amelia Jazwa, Manette T. Niu, Jane Baumblatt, Julianne Gee, Pedro L. Moro, Jonathan Duffy, Theresa Harrington, Michael M. McNeil, Karen R. Broder, John R. Su, Satoshi Kamidani, Christine K. Olson, Lakshmi Panagiotakopoulos, Tom T. Shimabukuro, Richard A. Forshee, Steven A. Anderson, Sarah D. Bennett

2021Vaccine79 citationsDOIOpen Access PDF

Topics & Concepts

VaccinationMedicinePandemicContext (archaeology)PopulationEnvironmental healthAdverse effectIncidence (geometry)DiseaseImmunologyInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)GeographyPathologyPhysicsOpticsInternal medicineArchaeologySARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research StudiesVaccine Coverage and Hesitancy
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines | Litcius